Successful Leadership during COVID-19 Phase 2

Program:

• 1. The evolution of guidelines. Dr. David Hoyt (USA).
• 2. Resource management. Ms. Linda Groah (USA).
• 3. Impact on hospital systems. Dr. Julie Freischlag (USA).
• 4. Managing a department. Dr. Scott Levin (USA).
• 5. Challenges in Latin America. Dr. Alberto Ferreres (Argentina).
• 6. How can specialty societies respond?. Dr. Joseph Bosco (USA).
• 7. J&J commitment & partnership with surgeons, hospitals & societies during Phase 2 of pandemic. Mr. Aldo Denti (USA).
• 8. Discussion. All faculty moderated by Dr. Steven Wexner (USA) and Dr. Patricia Turner (USA).

Faculty:

• Dr. David Hoyt (USA). Executive Director, American College of Surgeons (ACS).
• Ms. Linda Groah (USA). CEO of the Association of periOperative Registered Nurses (AORN).
• Dr. Julie Freischlag (USA). President-Elect of the American College of Surgeons, CEO of Wake Forest Baptist Health, Dean of Wake Forest School of Medicine in Winston-Salem.
• Dr. Scott Levin (USA). Chair, Department of Orthopedic Surgery, Perelman School of Medicine, University of Pennsylvania; Chair, ACS Board of Regents.
• Dr. Alberto Ferreres (Argentina). Professor and Chair of the Department of Surgery at the University of Buenos Aires.
• Dr. Patricia Turner (USA). Director, Division of Member Services, American College of Surgeons; past Chair, AMA Council on Medical Education; past Chair, Surgical Section, National Medical Association; past President, Society of Black Academic Surgeons; and Member, Board of Directors, Council on Medical Specialty Societies.
• Dr. Joseph Bosco (USA). President of the American Academy of Orthopaedic Surgeons (AAOS).
• Dr. Steven Wexner (USA). Director, Digestive Disease Institute, Chair, Department of Colorectal Surgery, Cleveland Clinic Florida, Vice-Chair, Board of Regents, American College of Surgeons.
• Mr. Aldo Denti (USA). Company Group Chairman, DePuy Synthes (J&J).